Literature DB >> 25613314

Identifying molecular targets to improve immune function in alcoholic hepatitis.

Ramon Bataller1, Pranoti Mandrekar2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25613314      PMCID： PMC4410810          DOI： 10.1053/j.gastro.2015.01.013

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  18 in total

1.  Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair.

Authors:  Jeremy S Duffield; Stuart J Forbes; Christothea M Constandinou; Spike Clay; Marina Partolina; Srilatha Vuthoori; Shengji Wu; Richard Lang; John P Iredale
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

Review 2.  Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?

Authors:  A R L Medford; A B Millar
Journal:  Thorax       Date:  2006-07       Impact factor: 9.139

3.  Vascular endothelial growth factor promotes fibrosis resolution and repair in mice.

Authors:  Liu Yang; Junghee Kwon; Yury Popov; Gabriella B Gajdos; Tamas Ordog; Rolf A Brekken; Debabrata Mukhopadhyay; Detlef Schuppan; Yan Bi; Douglas Simonetto; Vijay H Shah
Journal:  Gastroenterology       Date:  2014-02-04       Impact factor: 22.682

4.  Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.

Authors:  Frank Tacke; Henning W Zimmermann; Marie-Luise Berres; Christian Trautwein; Hermann E Wasmuth
Journal:  Liver Int       Date:  2011-03-10       Impact factor: 5.828

5.  Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B.

Authors:  Y O Kweon; Z D Goodman; J L Dienstag; E R Schiff; N A Brown; E Burchardt; R Schoonhoven; D A Brenner; M W Fried; E Burkhardt
Journal:  J Hepatol       Date:  2001-12       Impact factor: 25.083

6.  Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice.

Authors:  Christer Baeck; Xiao Wei; Matthias Bartneck; Viktor Fech; Felix Heymann; Nikolaus Gassler; Kanishka Hittatiya; Dirk Eulberg; Tom Luedde; Christian Trautwein; Frank Tacke
Journal:  Hepatology       Date:  2014-01-30       Impact factor: 17.425

7.  Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C.

Authors:  Marija Zeremski; Lydia M Petrovic; Luis Chiriboga; Queenie B Brown; Herman T Yee; Milan Kinkhabwala; Ira M Jacobson; Rositsa Dimova; Marianthi Markatou; Andrew H Talal
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

8.  Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans.

Authors:  Hermann E Wasmuth; Frank Lammert; Mirko Moreno Zaldivar; Ralf Weiskirchen; Claus Hellerbrand; David Scholten; Marie-Luise Berres; Henning Zimmermann; Konrad L Streetz; Frank Tacke; Sonja Hillebrandt; Petra Schmitz; Hildegard Keppeler; Thomas Berg; Edgar Dahl; Nikolaus Gassler; Scott L Friedman; Christian Trautwein
Journal:  Gastroenterology       Date:  2009-04-01       Impact factor: 22.682

Review 9.  Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.

Authors:  John P Iredale
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

10.  Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis.

Authors:  Jonathan A Fallowfield; Masashi Mizuno; Timothy J Kendall; Christothea M Constandinou; R Christopher Benyon; Jeremy S Duffield; John P Iredale
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422
View more
  6 in total

1.  Histopathological and Molecular Signatures of a Mouse Model of Acute-on-Chronic Alcoholic Liver Injury Demonstrate Concordance With Human Alcoholic Hepatitis.

Authors:  Shinji Furuya; Joseph A Cichocki; Kranti Konganti; Kostiantyn Dreval; Takeki Uehara; Yuuki Katou; Hisataka Fukushima; Hiroshi Kono; Igor P Pogribny; Josepmaria Argemi; Ramon Bataller; Ivan Rusyn
Journal:  Toxicol Sci       Date:  2019-08-01       Impact factor: 4.849

Review 2.  Infections in Alcoholic Hepatitis.

Authors:  Bhupinder Kaur; Russell Rosenblatt; Vinay Sundaram
Journal:  J Clin Transl Hepatol       Date:  2022-05-06

3.  LPS-TLR4 Pathway Mediates Ductular Cell Expansion in Alcoholic Hepatitis.

Authors:  Gemma Odena; Jiegen Chen; Juan Jose Lozano; Jose Altamirano; Daniel Rodrigo-Torres; Silvia Affo; Oriol Morales-Ibanez; Hiroshi Matsushita; Jian Zou; Raluca Dumitru; Juan Caballeria; Pere Gines; Vicente Arroyo; Min You; Pierre-Emmanuel Rautou; Dominique Valla; Fulton Crews; Ekihiro Seki; Pau Sancho-Bru; Ramon Bataller
Journal:  Sci Rep       Date:  2016-10-18       Impact factor: 4.379

Review 4.  Immune checkpoint receptors: homeostatic regulators of immunity.

Authors:  Antonio Riva; Shilpa Chokshi
Journal:  Hepatol Int       Date:  2018-05-08       Impact factor: 6.047

5.  Expansion of Granulocytic, Myeloid-Derived Suppressor Cells in Response to Ethanol-Induced Acute Liver Damage.

Authors:  Sha Li; Ning Wang; Hor-Yue Tan; Ming Hong; Man-Fung Yuen; Huabin Li; Yibin Feng
Journal:  Front Immunol       Date:  2018-07-19       Impact factor: 7.561

6.  Hepatic lipocalin 2 promotes liver fibrosis and portal hypertension.

Authors:  Jiegen Chen; Josepmaria Argemi; Gemma Odena; Ming-Jiang Xu; Yan Cai; Veronica Massey; Austin Parrish; Rajanikanth Vadigepalli; Jose Altamirano; Joaquin Cabezas; Pere Gines; Juan Caballeria; Natasha Snider; Pau Sancho-Bru; Shizuo Akira; Ivan Rusyn; Bin Gao; Ramon Bataller
Journal:  Sci Rep       Date:  2020-09-23       Impact factor: 4.996
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.